跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
欣普尼 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Golimumab Injection
Approved
生物制品
Golimumab Injection
Janssen Biologics BV
🇨🇳 National Medical Products Administration
Approval Date
Oct 10, 2024
Approval ID
87u9235M1py
Company
Janssen Biologics BV
Type
生物制品
Approval Details
Approval Id
87u9235M1py
Approval Number
国药准字SJ20202003
Generic Name
戈利木单抗注射液
Generic Name En
Golimumab Injection
Trade Name
欣普尼
Brand Name
欣普尼
Drug Type
生物制品
Dosage Form
注射剂
Strength
50mg(0.5ml)/支(预充笔式注射器)
Reg Date
2024-10-10
Expired Date
2029-10-09
Company Name
Janssen Biologics BV
Production Company Name
Cilag AG
Company Detail Path
/organization/janssen-biologics-bv
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 10, 2024
Approval ID
87u9235M1py
Type
生物制品
Back to NMPA Approvals